Wednesday May 27th, 2020, 13:00-16:45 CEST, the TransPot consortium will hold a virtual mini conference to showcase the results of the project that is settling to finalize and give a platform to invited speakers within the prostate cancer and biomarker discovery field. Both Mario Canjiano and Ingrid Tomljanovic will present their work. You are invited to join the mini conference…
As a company with close partnerships within medical centers and hospitals, GenomeScan is aware that reliable access to your sequencing data can be of crucial importance to your patients or your study. Thanks to our online platforms and Bio-IT infrastructure, our ongoing projects with laboratories in life science, healthcare and pharmaceutical industries proceed without interruption, despite the challenges many service…
Project management via digital platforms The coronavirus outbreak is impacting the way we live, changing the way we work and transforming the way we communicate with each other. We know that the spread of COVID-19 does not remove the need to access high-quality scientific support and advice. Many laboratories in life science, healthcare and pharmaceutical industries are being affected by…
“In these unique circumstances, our team is dedicating its time, expertise and talents to support the healthcare and scientific communities and their scientific programs.” GenomeScan has a crucial function and stays operational GenomeScan fully understands the measures announced recently by the Dutch government and is stepping up to the challenge ahead. Kees van den Berg, CEO of GenomeScan summarizes…
The new coronavirus presents one of the most serious challenges we have ever faced. Laboratories are expected to provide consistent performance. Due to the COVID-19 outbreak and related uncertainties, it is quite a challenge to perform laboratory tests at the usual quality level. Quality and compliance at GenomeScan At GenomeScan, it is the task of the QA Department to make…
The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe while still offering the best possible service. Visitor’s notice Under normal circumstances access to GenomeScan’s laboratory is limited to authorized individuals in order to safeguard laboratories and secure important research equipments…
GenomeScan’s activities during this unprecedent Coronavirus crisis GenomeScan is first and foremost concerned with the health of its staff, community and the larger public. The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe, while still offering the best possible service….
The epigentics of melanoma. DNA is often methylated at the cytosine (C) base if the C is followed by a G base. Instead of a methylated or non-methylated C, one may also find 5-hydroxymethyl-C (hmC) at this position. GenomeScan has joined the MELGEN consortium to investigate the role of hmC in melanoma. Last month, Catarina Salgado and co-workers from the…
FASTER, BETTER, AFFORDABLE. BiotechNEWS has recently interviewed our CEO, Kees van den Berg. According to Kees, the future of diagnostics is all about personalized medicine. In this article (in Dutch), he describes the expansion of GenomeScan and the relationship with LUMC and ErasmusMC. He also highlights the current trends in NGS and comments on future developments in healthcare. Enjoy… Published…
